CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes
Clinical trial NCT02912455 · TERMINATED
Trial details
- NCT number
- NCT02912455
- Sponsor
- The Cleveland Clinic
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-05
- Primary completion
- 2018-07-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.